|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
WO2004084936A2
(en)
|
2003-02-06 |
2004-10-07 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
DK1592441T3
(da)
|
2003-02-06 |
2012-05-14 |
Aduro Biotech |
Listeria, hvis indtrængen i ikke-phagocytiske celler er svækket, vacciner omfattende listeria og fremgangsmåder til anvendelse deraf
|
|
WO2004091375A2
(en)
*
|
2003-04-11 |
2004-10-28 |
Medimmune, Inc. |
Epha2 and non-neoplastic hyperproliferative cell disorders
|
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
US7612162B2
(en)
*
|
2004-09-21 |
2009-11-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
|
US20120052080A1
(en)
*
|
2004-09-21 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
AU2005295158A1
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Llc |
High cell density process for growth of Listeria
|
|
US20060122138A1
(en)
*
|
2004-10-27 |
2006-06-08 |
Medimmune, Inc. |
Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related disease
|
|
DE102006004612A1
(de)
*
|
2006-02-01 |
2007-08-16 |
Ralf Dr. med. Jochem |
Therapeutische Zusammensetzung zur Vorbeugung und Bekämpfung von Knochenmetastasen
|
|
EP2860253B1
(en)
|
2006-03-01 |
2018-08-01 |
Aduro Biotech, Inc. |
Engineered listeria and methods of use thereof
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US20070207171A1
(en)
*
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
WO2007103261A2
(en)
*
|
2006-03-01 |
2007-09-13 |
Medimmune, Inc. |
Listeria-based epha2 immunogenic compositions
|
|
WO2008094188A2
(en)
|
2006-07-17 |
2008-08-07 |
Anza Therapeutics, Inc. |
Methods and compositions using listeria for enhancing immunogenicity by prime boost
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
EP2061800B1
(en)
*
|
2006-08-15 |
2015-07-29 |
The Trustees of the University of Pennsylvania |
Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
|
|
SI2199390T1
(sl)
|
2007-08-30 |
2017-02-28 |
Daiichi Sankyo Company, Limited |
Proti-epha2 protitelo
|
|
WO2009044272A2
(en)
*
|
2007-10-04 |
2009-04-09 |
000'npt Mbp Gormezis' |
Laser-based vaccine adjuvants
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
US20140234370A1
(en)
*
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
EP2853269B1
(en)
|
2008-05-19 |
2019-05-01 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens comprising a recombinant Listeria strain attenuated by mutation of dal/dat and deletion of ActA comprising a nucleic acid molecule encoding an listeriolysin O - prostate specific anigen fusion protein
|
|
CN102076843A
(zh)
|
2008-05-19 |
2011-05-25 |
艾杜罗生物科技公司 |
包含prfa*突变体李斯特菌的组合物及其使用方法
|
|
US9017660B2
(en)
*
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
WO2010071769A2
(en)
*
|
2008-12-12 |
2010-06-24 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Chimeric l. monocytogens in1b protein
|
|
WO2010102140A1
(en)
|
2009-03-04 |
2010-09-10 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising angiogenic factors and methods of use thereof
|
|
EP2498808A4
(en)
*
|
2009-11-11 |
2014-01-08 |
Advaxis |
COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
|
|
US10016617B2
(en)
*
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
US9128101B2
(en)
|
2010-03-01 |
2015-09-08 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarkers for theranostics
|
|
WO2011127219A1
(en)
|
2010-04-06 |
2011-10-13 |
Caris Life Sciences Luxembourg Holdings |
Circulating biomarkers for disease
|
|
JP5977737B2
(ja)
|
2010-05-23 |
2016-08-24 |
アデュロ バイオテック |
癌の補助薬物療法でリステリアを使用する方法および組成物
|
|
GB2482536B
(en)
*
|
2010-08-05 |
2013-07-24 |
Hera Pharmaceuticals Inc |
Expression of antibody or a fragment thereof in lactobacillus
|
|
CN103282048B
(zh)
|
2010-10-01 |
2017-05-17 |
宾夕法尼亚大学理事会 |
李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途
|
|
EP2446895A1
(en)
*
|
2010-10-01 |
2012-05-02 |
Stemgen S.P.A. |
EPH receptor expression in tumor stem cells
|
|
CA2829960A1
(en)
|
2011-03-11 |
2012-09-20 |
John Rothman |
Listeria-based adjuvants
|
|
EP2764082B1
(en)
|
2011-10-04 |
2018-05-23 |
Expression Pathology, Inc. |
Srm/mrm assay for the ephrin type-a receptor 2 protein
|
|
KR20140134695A
(ko)
|
2012-03-12 |
2014-11-24 |
어드박시스, 인크. |
리스테리아 백신 치료 후 억제 세포 기능 저해
|
|
RS62406B1
(sr)
|
2012-05-16 |
2021-10-29 |
Stemline Therapeutics Inc |
Vakcine protiv kancera sa ciljanim delovanjem na matične ćelije kancera
|
|
NZ702392A
(en)
|
2012-06-08 |
2017-03-31 |
Aduro Biotech |
Compositions and methods for cancer immunotherapy
|
|
HK1213008A1
(zh)
|
2012-11-06 |
2016-06-24 |
艾杜罗生物科技公司 |
兼性减毒细菌种类及其制备和使用方法
|
|
EA201590396A1
(ru)
|
2012-12-13 |
2015-12-30 |
Адуро Биотек, Инк. |
Композиция, содержащая циклические пуриновые динуклеотиды с определенной стереохимией, и способ ее получения и применения
|
|
MX2015008329A
(es)
|
2012-12-27 |
2016-03-01 |
Aduro Biotech Inc |
Compañeros de fusion de peptido, señal que facilita la expresion listeral de secuencias antigenicas y metodos de preparacion y uso de los mismos.
|
|
EP2992000B1
(en)
|
2013-05-03 |
2020-07-08 |
The Regents of The University of California |
Cyclic di-nucleotide induction of type i interferon
|
|
ME03586B
(me)
|
2013-05-18 |
2020-07-20 |
Univ California |
Sastavi i metode za aktiviranje signaliziranja koje je zavisno od .,stimulatora gena za interferon"
|
|
US9549944B2
(en)
|
2013-05-18 |
2017-01-24 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
|
|
MX2016014367A
(es)
*
|
2014-05-02 |
2017-06-30 |
Univ Pennsylvania |
Combinación de inmunoterapia y radioterapia para el tratamiento de canceres positivos a her-2.
|
|
US10925945B2
(en)
|
2014-10-13 |
2021-02-23 |
Providence Health & Services-Oregon |
Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof
|
|
US20160228530A1
(en)
*
|
2014-10-14 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Combination therapy for use in cancer therapy
|
|
WO2016073381A1
(en)
|
2014-11-03 |
2016-05-12 |
Cerus Corporation |
Compositions and methods for improved car-t cell therapies
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
WO2016210374A1
(en)
|
2015-06-26 |
2016-12-29 |
Cerus Corporation |
Cryoprecipitate compositions and methods of preparation thereof
|
|
EP3364986B1
(en)
|
2015-10-23 |
2023-12-13 |
Cerus Corporation |
Pathogen-inactivated cryo-poor plasma and methods of use thereof
|
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
EA201991506A1
(ru)
|
2016-12-23 |
2020-01-23 |
Сирус Корпорейшн |
Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
|
|
CN110573169B
(zh)
|
2017-03-03 |
2024-10-01 |
塞鲁斯公司 |
制备病原体灭活的血小板组合物的试剂盒和方法
|
|
CN116571191A
(zh)
|
2017-12-29 |
2023-08-11 |
塞鲁斯公司 |
用于处理生物流体的系统和方法
|
|
JP7571063B2
(ja)
|
2019-06-22 |
2024-10-22 |
シーラス コーポレイション |
生物学的流体の処理を実施するシステム及び方法
|
|
CN114173842A
(zh)
|
2019-06-22 |
2022-03-11 |
塞鲁斯公司 |
生物流体处理系统
|
|
WO2020264421A1
(en)
|
2019-06-28 |
2020-12-30 |
Cerus Corporation |
System and methods for implementing a biological fluid treatment device
|
|
CN114015644A
(zh)
*
|
2021-11-05 |
2022-02-08 |
成都生物制品研究所有限责任公司 |
一种单一病毒收获液的生产方法
|
|
CN114848654B
(zh)
*
|
2022-04-18 |
2024-04-05 |
武汉大学 |
阿司匹林在制备用于引起肿瘤免疫原性细胞死亡的药物中的应用
|